Study of Recombinant Human Thrombin for Bleeding During Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

401

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

June 30, 2006

Study Completion Date

July 31, 2006

Conditions
Surgical Hemostasis
Interventions
BIOLOGICAL

rThrombin

1000 U/mL applied topically in combination with absorbable gelatin sponge

DRUG

bovine thrombin

1000 U/mL applied topically in combination with absorbable gelatin sponge

Trial Locations (29)

10029

Mt. Sinai School of Medicine, New York

15213

University of Pittsburgh Medical Center, Pittsburgh

22908

University of Virginia, Charlottesville

27710

Duke University Medical Center, Durham

32501

Baptist Clinical Research, Pensacola

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

35213

Cardio Thoracic Surgeons, P.C., Birmingham

35235

Cardio Thoracic Surgeons, P.C., Medical Center East / Baptist Montclair, Birmingham

35294

University of Alabama at Birmingham, Birmingham

37232

Vanderbilt University Medical Center, Nashville

40509

Bluegrass Orthopedics/Bluegrass Musculoskeletal Research, Lexington

46260

Indiana Spine Group, Indianapolis

48201

VAMC Clinical Research Center, Detroit

60611

Northwestern Memorial Hospital, Chicago

Northwestern University Vascular Surgery, Chicago

63110

Washington University School of Medicine, St Louis

70112

Tulane University Abdominal Transplant, New Orleans

70809

Vascular Surgery Associates, Baton Rouge

76107

University of North Texas Science Center at Fort Worth, Fort Worth

78229

Clinical Trials of Texas, San Antonio

84107

Physician's Research Options, LLC/The Intermountain Spine Institute, Murray

84132

University of Utah, Salt Lake City

90033

University of Southern California, Keck School of Medicine, Los Angeles

90333

University of Southern California, Keck School of Medicine, Los Angeles

91007

Methodist Hospital, Arcadia

91105

Huntington Memorial Hospital, Pasadena

91206

Glendale Adventist Medical Center, Glendale

98101

Virginia Mason Medical Center, Seattle

98104

Harborview Medical Center, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ZymoGenetics

INDUSTRY

NCT00245336 - Study of Recombinant Human Thrombin for Bleeding During Surgery | Biotech Hunter | Biotech Hunter